BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6089320)

  • 1. Angiotensin I-converting enzyme inhibition after renal transplantation.
    Grönhagen-Riska C; Fyhrquist F; Ahonen J; von Willebrand E; Häyry P
    Scand J Urol Nephrol Suppl; 1984; 79():63-7. PubMed ID: 6089320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin I-Converting Enzyme Inhibition After Renal Transplantation.
    Grönhagen-Riska C; Fyhrquist F; Ahonen J; Willebrand EV; Häyry P
    Scand J Urol Nephrol; 1984 Jul; 18(sup79):63-67. PubMed ID: 27786007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril-associated granulocytopenia in hypertension after renal transplantation.
    Shindo K; Matsuya F; Ura T; Jodai A; Shimomae H; Kuniyoshi M; Hirose T; Kusaba Y; Saito Y
    Clin Nephrol; 1984 Dec; 22(6):314-6. PubMed ID: 6396008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
    Walter NM; Whitworth JA; Kincaid-Smith P
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril in hypertension after renal transplantation.
    Herlitz H; Ahlmén J; Aurell M; Blohmé I; Brynger H; Delin K; Larsson O
    Scand J Urol Nephrol Suppl; 1984; 79():111-4. PubMed ID: 6382584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension and stenosis of the graft artery: effects of conversion enzyme inhibition].
    Mourad G; Ribstein J; Argiles A; Mion C; Mimran A
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):892-5. PubMed ID: 3099707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants.
    Gantenbein MH; Bauersfeld U; Baenziger O; Frey B; Neuhaus T; Sennhauser F; Bernet V
    J Perinat Med; 2008; 36(5):448-52. PubMed ID: 18605972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive reversible kidney insufficiency after blood pressure reduction with captopril].
    Kindler J; Konrads A; Meurer KA; Sieberth HG
    Internist (Berl); 1981 Jun; 22(6):360-3. PubMed ID: 6265394
    [No Abstract]   [Full Text] [Related]  

  • 10. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
    Luft FC; Aronoff GR; Evan AP; Connors BA; Weinberger MH; Kleit SA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):433-9. PubMed ID: 6276536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deterioration of renal function after converting enzyme inhibition in a patient with renal artery stenosis after transplantation.
    Van Son WJ; Donker AJ; Van der Woude FJ; Meijer S; Slooff MJ; Tegzess AM; Van der Slikke LB
    Neth J Med; 1984; 27(1):10-3. PubMed ID: 6324009
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renal insufficiency after administration of captopril in renal artery stenosis with a single kidney or bilateral stenosis is not compulsory].
    Durand D; Tran Van T; Ader JL; Suc JM
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1272-7. PubMed ID: 6441547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of recovery in postischemic acute renal failure with captopril.
    Magnusson MO; Rybka SJ; Stowe NT; Novick AC; Straffon RA
    Kidney Int Suppl; 1983 Dec; 16():S324-6. PubMed ID: 6376920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the renal nerves and angiotensin II in the renal function curve.
    Golin R; Genovesi S; Castoldi G; Wijnmaalen P; Protasoni G; Zanchetti A; Stella A
    Arch Ital Biol; 1999 Aug; 137(4):289-97. PubMed ID: 10443320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of captopril, an angiotensin converting enzyme inhibitor, on the massive proteinuria due to chronic rejection after renal transplantation--a prospective study.
    Morales JM; Andres A; Montoyo C; Praga M; Alcazar JM; Algranati L; Rodicio JL
    Transplant Proc; 1992 Feb; 24(1):92-3. PubMed ID: 1539354
    [No Abstract]   [Full Text] [Related]  

  • 18. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril-induced acute renal failure in a kidney transplant recipient.
    Hays R; Aquino A; Lee BB; Lo R; Currier CB
    Clin Nephrol; 1983 Jun; 19(6):320-1. PubMed ID: 6347492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and vascular effects of S21402, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, in healthy subjects with hypovolemia.
    Chodjania Y; Tharaux PL; Ragueneau I; Dussaule JC; Picker JL; Funck-Brentano C; Jaillon P
    Clin Pharmacol Ther; 2002 Jun; 71(6):468-78. PubMed ID: 12087350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.